Wolverine Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,000
| Closed | -$77.6K | – | 1952 |
|
|
2025
Q4 | $77.6K | Sell |
3,000
-8,628
| -74% | -$205K | ﹤0.01% | 1221 |
|
|
2025
Q3 | $300K | Hold |
11,628
| – | – | ﹤0.01% | 949 |
|
|
2025
Q2 | $278K | Hold |
11,628
| – | – | ﹤0.01% | 981 |
|
|
2025
Q1 | $289K | Buy |
+11,628
| New | +$278K | 0.01% | 951 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1850 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1852 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1847 |
|
|
2022
Q2 | – | Sell |
-10,459
| Closed | -$798K | – | 2483 |
|
|
2022
Q1 | $798K | Buy |
+10,459
| New | +$697K | 0.01% | 839 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2420 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2276 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1895 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1783 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1668 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1613 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1694 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1620 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1433 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1366 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3022 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 2979 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 2836 |
|
Other funds holding PCRX
DPCM
VPM
VCM